deoxy · news / FDA MedWatch Safety Alerts

   
 
 Home · About · Category · CloudToday · Digest · MyNews · Search

          
FDA MedWatch Safety Alerts
Fri May 25 19:46:42 2012 GMT
  » FEEDSITE

  • Baxa Corporation Abacus Total Parenteral Nutrition (TPN) Calculation Software: Class I Recall - Pote...
  • Dialysate Concentrates Used in Hemodialysis: Safety Communication - Alkali Dosing Errors
  • Franck’s Compounding Pharmacy Sterile Preparations: Reports of Fungal Endophthalmitis, Expande...
  • Hospira Carpuject Pre-filled Cartridges - Drug Alert: Products May Contain More Than the Intended Fi...
  • West Coast Nutritionals Dietary Supplement Products: Recall - Undeclared Drug Ingredient
  • Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
  • Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First ...
  • Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Co...
  • Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies
  • Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians
  • Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor D...
  • X-Rock: Recall - Undeclared Drug Ingredient
  • Roche Diagnostics Operations Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays: Recall &nd...
  • Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fu...
  • Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
  • Other‐Sonic Generic Ultrasound Transmission Gel: Safety Communication - Risk of Bacterial Con...
  • Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recal...
  • Birth Control Pills Containing Drospirenone: Label Change-Products may be associated with a higher r...